Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-26-008970
Filing Date
2026-09-01
Accepted
2026-09-01 16:57:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3553
  Complete submission text file 0001950047-26-008970.txt   5155
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37722 | Film No.: 261351613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SPYRE THERAPEUTICS, INC. 221 CRESCENT STREET, BLDG 23, SUITE 105 WALTHAM MA 02453
Business Address
King-Jones Heidy (Reporting) CIK: 0001794898 (see all company filings)

Type: 144